Immunotherapy for Glioblastomas
Glioblastoma (GBM), a WHO grade IV brain tumor, is an aggressive tumor with poor prognosis; even with current standard care of triple therapy, consisting of surgical resection, chemo and radiation therapy, the patients' median survival time is only approximately 15 months. Recent practice shows...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Ebooks |
| Published: |
IntechOpen,
2020-04-02.
|
| Subjects: | |
| Online Access: | Get Online |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!